PTGS2 and polycystic ovary syndrome: Regarding PCOS, the primary outcome proposed for the omega-3 fatty acids includes the change on the homeostatic model assessment (HOMA) index of IR, because these fatty acids can decrease the biosynthesis of prostaglandins through competitive inhibition of Cyclooxygenase-2 (COX-2).